Relay Therapeutics's total assets for Q2 2025 were $728.84M, a decrease of -8.82% from the previous quarter. RLAY total liabilities were $63.18M for the fiscal quarter, a -19.29% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.